Santen Pharmaceutical Investor
Santen is a Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products.
Last Funding Type:
Series D
Funding Status:
M&A
Headquarters:
United States
Founded Date:
1890-01-01
Last Funding Date:
2009-09-26
Total Funding:
59000000 EUR
Employee Number:
1001-5000
Number Of Exists:
3
Investors Number:
8
Industry:
Biotechnology, Health Care, Manufacturing, Science and Engineering